Healthcare provider profile · identity verified

Anthony G Amon, M.D.

Emergency Medicine · WILLMAR, MN · NPI 1972526564

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	487	132
Lisinopril	Lisinopril	460	122
Omeprazole	Omeprazole	402	103
Amlodipine Besylate	Amlodipine Besylate	358	93
Levothyroxine Sodium	Levothyroxine Sodium	316	61
Losartan Potassium	Losartan Potassium	288	74
Metoprolol Succinate	Metoprolol Succinate	234	67
Hydrochlorothiazide	Hydrochlorothiazide	231	69
Simvastatin	Simvastatin	221	54
Gabapentin	Gabapentin	191	51
Rosuvastatin Calcium	Rosuvastatin Calcium	185	60
Tamsulosin Hcl	Tamsulosin Hcl	174	58
Metformin Hcl	Metformin Hcl	164	49
Allopurinol	Allopurinol	145	37
Valsartan	Valsartan	140	35
Furosemide	Furosemide	137	38
Potassium Chloride	Potassium Chloride	115	40
Sertraline Hcl	Sertraline Hcl	113	21
Citalopram Hbr	Citalopram Hydrobromide	110	24
Donepezil Hcl	Donepezil Hcl	110	17
Ozempic	Semaglutide	101	17
Atenolol	Atenolol	98	18
Warfarin Sodium	Warfarin Sodium	97	25
Tramadol Hcl	Tramadol Hcl	93	17
Jantoven	Warfarin Sodium	92	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	90	23
Pravastatin Sodium	Pravastatin Sodium	81	20
Pantoprazole Sodium	Pantoprazole Sodium	78	23
Eliquis	Apixaban	77	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	75	15
Prednisone	Prednisone	75	46
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	74	16
Metformin Hcl Er	Metformin Hcl	74	18
Zolpidem Tartrate	Zolpidem Tartrate	74	15
Escitalopram Oxalate	Escitalopram Oxalate	71	13
Glimepiride	Glimepiride	69	20
Jardiance	Empagliflozin	69	15
Carvedilol	Carvedilol	61	17
Fluticasone Propionate	Fluticasone Propionate	61	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	59	14
Duloxetine Hcl	Duloxetine Hcl	57	15
Spironolactone	Spironolactone	57	16
Montelukast Sodium	Montelukast Sodium	54	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	15
Triamcinolone Acetonide	Triamcinolone Acetonide	53	28
Xarelto	Rivaroxaban	47	13
Methocarbamol	Methocarbamol	45	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	41	34
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	11
Buspirone Hcl	Buspirone Hcl	40	suppressed
Bupropion Xl	Bupropion Hcl	39	14
Ventolin Hfa	Albuterol Sulfate	37	12
Cephalexin	Cephalexin	36	32
Ezetimibe	Ezetimibe	36	11
Trazodone Hcl	Trazodone Hcl	36	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	36	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	35	16
Clopidogrel	Clopidogrel Bisulfate	35	13
Oxybutynin Chloride Er	Oxybutynin Chloride	35	suppressed
Alendronate Sodium	Alendronate Sodium	33	suppressed
Clonazepam	Clonazepam	32	suppressed
Levetiracetam	Levetiracetam	32	suppressed
Famotidine	Famotidine	31	14
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Januvia	Sitagliptin Phosphate	30	suppressed
Solifenacin Succinate	Solifenacin Succinate	30	suppressed
Lorazepam	Lorazepam	28	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Pregabalin	Pregabalin	27	suppressed
Alprazolam	Alprazolam	26	suppressed
Trospium Chloride Er	Trospium Chloride	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Humalog Kwikpen U-100	Insulin Lispro	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Klor-Con M10	Potassium Chloride	24	suppressed
Mirtazapine	Mirtazapine	24	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	22	19
Alfuzosin Hcl Er	Alfuzosin Hcl	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Nystatin	Nystatin	21	12
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Divalproex Sodium Er	Divalproex Sodium	20	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	19	suppressed
Cefdinir	Cefdinir	19	16
Divalproex Sodium	Divalproex Sodium	19	suppressed
Klor-Con M20	Potassium Chloride	19	suppressed
Methylprednisolone	Methylprednisolone	19	17
Chlorthalidone	Chlorthalidone	18	suppressed
Naproxen	Naproxen	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Lovastatin	Lovastatin	16	suppressed
Serevent Diskus	Salmeterol Xinafoate	15	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Finasteride	Finasteride	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Colchicine	Colchicine	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Terbinafine Hcl	Terbinafine Hcl	13	suppressed
Torsemide	Torsemide	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Loxapine	Loxapine Succinate	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Azithromycin	Azithromycin	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Glipizide	Glipizide	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Lorazepam Intensol	Lorazepam	11	suppressed
Topiramate	Topiramate	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error